EU Approves Epidyolex to Treat Severe Epilepsy in Children

The European Union has approved its first medical cannabis product in order to help doctors across the continent treat children with severe epilepsy. Epidyol... Read More»

cannabis / marijuana supply / greenhouses - mj

Earnings Update: Second GW Pharmaceuticals Stock Price Increase After February’s Alzheimer’s Trial News

GW Pharmaceuticals (NASDAQ: GWPH) has been on a tear over the past month after exceeding expectations with its Q4 results, which were released at the end of Feb... Read More»

Epidiolex Maker GW Pharmaceuticals Raises $345 Million Through Share Sale

British medicinal marijuana producer GW Pharmaceuticals (NASDAQ: GWPH) has raised $345 million to fund an expansion drive after releasing 2.18 million shares on... Read More»

Marijuana News – Weekly Investor Roundup (August 11th)

Germany Will Disappoint Cannabis Investors The German government is making sure the domestic cannabis market develops slowly and is taking unusual steps in t... Read More»

Marijuana News: Weekly Investor Roundup (June 23rd)

Cannabis bill receives Royal Assent in Canada, almost law After the successful Senate vote on cannabis legalization last week, the bill (C-45) received Roy... Read More»

Marijuana News: Weekly Investor Roundup (June 15th)

Argument between House and Senate delays Marijuana Bill After the successful Senate vote on cannabis legalization last week, the bill (C-45) was sent back to... Read More»

Investing in Medical Marijuana Stocks – Quantifying the Upside

The argument for marijuana as a legitimate medicine is rapidly gaining momentum as more and more clinical studies are released. The illegal nature of marijuana ... Read More»

GW Pharmaceuticals plc